6533b7dbfe1ef96bd1271323

RESEARCH PRODUCT

ChemInform Abstract: Synthesis of New 3-(3-Phenyl-isoxazol-5-yl) or 3-[(3-Phenyl-isoxazol-5-yl)amino] Substituted 4(3H)-Quinazolinone Derivatives with Antineoplastic Activity.

Fulvio PlesciaBenedetta MaggioDemetrio RaffaGiuseppe DaidoneDomenico Schillaci

subject

chemistry.chemical_compoundchemistryCell cultureStereochemistryIc50 valuesGeneral MedicineQuinazolinoneIn vitro

description

A novel series of 3-(3-phenyl-isoxazol-5-yl) or 3-[(3-phenyl-isoxazol-5-yl)amino] substituted 4(3H)-quinazolinone derivatives was synthesized. The compounds were tested for their antineoplastic activity in vitro against Raji (human Burkitt limphoma). K-562 (human chronic myelogeneous leukemia) and U937 (human histiocytic limphoma) cell lines. The most active quinazolinones showed IC50 values in the range 16-30 microM.

https://doi.org/10.1002/chin.199931194